Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Carmen Fontela"'
Autor:
Dulce Maria Calvo, Luis Carlos Saiz, Leire Leache, Maria Concepción Celaya, Marta Gutiérrez‐Valencia, Alvaro Alonso, Juan Erviti, Natalia Alzueta, Amaya Echeverría, Javier Garjón, Carmen Fontela, Lorea Sanz, Maria Teresa Acín, Maria Loreto Fernández, Nerea Gómez
Publikováno v:
Pharmacoepidemiology and Drug Safety.
Autor:
Carmen Ezpeleta, Jesús Repáraz, Conchi Moreno-Iribas, Aitziber Aguinaga, María Gracia, María Rivero, Y Floristán, Carmen Fontela, Ramón San Miguel, Ujué Fresán, Jesús Castilla
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Combination antiretroviral therapy reduces mortality of HIV-infected persons. In Spain, where this therapy is widely available, we aim to evaluate mortality trends and causes of death in HIV-infected adults, and to estimate the excess mortality compa
Autor:
Natalia Larrea, Aisling O'Leary, Ramón San Miguel, Carmen Fontela, Jesús Castilla, Iván Martínez-Baz, María Rivero, Regina Juanbeltz
Publikováno v:
Postgraduate Medicine. 130:317-324
The increased survival of HIV-infected individuals has resulted in a premature aging of this population, with the consequent development of premature age-related comorbidities and risk factors. We aimed to describe the prevalence of age-related comor
Publikováno v:
Medicina Clínica. 156:465-466
Autor:
Lidia Montenegro, Teresa Acin, Natalia Alzueta, Javier Garjón, Lorea Sanz, Carmen Fontela, Amaya Echeverria
Publikováno v:
Eur J Hosp Pharm
A possible case of sprue-like enteropathy (SLE) induced by the use of telmisartan is reported. Telmisartan is an angiotensin-receptor II blocker (type 1) used for the treatment of hypertension. Several cases of SLE associated with olmesartan and othe
Autor:
MC Celaya, Natalia Alzueta, MT Acin, N Gómez, Amaya Echeverria, A López, ML Fernandez, Javier Garjón, Lorea Sanz, Carmen Fontela
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Concomitant treatment with renin-angiotensin system inhibitors (ACEI/ARB), diuretics and non-steroidal anti-inflammatory drugs (NSAID) has been named as triple whammy (TW). This interaction can produce acute kidney injury (AKI). Purpose To
Autor:
Maria Resano, Leire Leache, Carmen Fontela, Amaya Echeverria, Teresa Acin, Natalia Alzueta, Iker Zuazu, Maria Concepción Celaya, Lorea Sanz, Javier Garjón
Publikováno v:
Poster presentations.
Objectives Medication review consists of a structured evaluation of the patient‘s treatment, with the objective of increasing health benefits and minimizing the risks associated with the medication. The review includes prevention, identification, n
Autor:
Teresa Acin, Leire Leache, Natalia Alzueta, Amaya Echeverria, Cristina Agudo, Lorea Sanz, Maria Concepción Celaya, Javier Garjón, Carmen Fontela
Publikováno v:
Poster presentations.
Objectives To evaluate the impact of a strategy for the optimization of the urinary incontinence treatment in patients with diapers. In aged patients, the use of drugs for urinary incontinence contributes to increase the risk of suffering adverse eff
Autor:
Carmen Fontela, Natalia Alzueta, Maria Concepción Celaya, Amaya Echeverria, Javier Garjón, Leire Leache, Lorea Sanz, Teresa Acin, Antonio López
Publikováno v:
Poster presentations.
Objectives Proton pump inhibitors (PPI) are the most consumed drugs and omeprazole is one of the most prescribed drugs in our health system. It has been estimated that 10% of people in our region take a PPI daily. Prescribing a PPI without indication
Autor:
A Iruin, M de Miguel, M Sarobe, María José Sánchez, M Etxeberria, Carmen Fontela, R San Miguel, Juan A. Fernández, Natalia Larrea
Publikováno v:
Clinical pharmacy.
Background Nivolumab is approved by the US Food and Drug Administration for the treatment of patients with melanoma, metastatic non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC), and has been included in our hospital’s formulary sin